Indian Pharmaceutical Company conducts Clinical Analysis for the Supplement to battle against Post COVID-19 difficulties
Pooja Verma ImmunoSEB + ProbioSEB CSC3 for post-resolution of mild to moderate COVID-19 patients Mumbai, Maharashtra , June 21: According…
ImmunoSEB + ProbioSEB CSC3 for post-resolution of mild to moderate COVID-19 patients Mumbai, Maharashtra , June 21: According…